Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2020

May 14, 2020

SELL
$32.73 - $50.78 $490,949 - $761,700
-15,000 Closed
0 $0
Q4 2019

Feb 10, 2020

SELL
$6.81 - $39.55 $678,296 - $3.94 Million
-99,603 Reduced 86.91%
15,000 $593,000
Q3 2019

Nov 12, 2019

BUY
$6.47 - $8.96 $515,031 - $713,242
79,603 Added 227.44%
114,603 $777,000
Q1 2019

May 14, 2019

BUY
$10.01 - $13.89 $350,350 - $486,150
35,000 New
35,000 $486,000

Others Institutions Holding CCXI

About ChemoCentryx, Inc.


  • Ticker CCXI
  • Exchange NASDAQ
  • Shares Outstandng 71,919,696
  • Market Cap $3.68M
  • Description
  • ChemoCentryx, Inc., a biopharmaceutical company, focuses on the development and commercialization of new medications for inflammatory disorders, autoimmune diseases, and cancer in the United States. It offers TAVNEOS (avacopan), an orally administered selective C5aR inhibitor for the treatment of adult patients with severe active anti-neutrophil...
More about CCXI
Track This Portfolio

Track Employees Retirement System Of Texas Portfolio

Follow Employees Retirement System Of Texas and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Employees Retirement System Of Texas, based on Form 13F filings with the SEC.

News

Stay updated on Employees Retirement System Of Texas with notifications on news.